Nearly $20 Billion in Play: A Bold Pivot from Traditional Aid (Image Credits: Unsplash)
The United States has formalized bilateral health agreements with 24 countries, signaling a major shift in its global health approach. These memorandums of understanding, part of the America First Global Health Strategy unveiled in September 2025, emphasize partner nations’ co-investments and long-term self-reliance.[1][2] Implementation of these five-year plans, covering 2026 to 2030, began taking shape earlier this year. The pacts total nearly $20 billion, with recipient governments committing roughly 37 percent of the funding.[2]
Nearly $20 Billion in Play: A Bold Pivot from Traditional Aid
The scale of these commitments underscores the strategy’s ambition. Partner countries pledged billions in domestic health spending increases alongside U.S. contributions.[2] This model replaces much of the previous reliance on multilateral organizations and nongovernmental implementers with direct government-to-government cooperation.
Released by the State Department, the America First Global Health Strategy prioritizes protecting U.S. interests by containing infectious diseases abroad. It targets high-burden areas in Sub-Saharan Africa, Southeast Asia, and Latin America. Core principles include performance benchmarks, streamlined data systems, and procurement favoring U.S. innovations.[3]
USAID’s dissolution accelerated this transition. Responsibilities shifted to the State Department, which now oversees procurement and partnerships. Bridge funding ensured continuity through early 2026.
Core Priorities: HIV, TB, Malaria, and Beyond
HIV/AIDS and maternal-child health feature prominently across the agreements. The U.S. aims for ambitious targets, such as a 90 percent reduction in new HIV infections and ending mother-to-child transmission in key nations.[3] Tuberculosis, malaria, and polio eradication efforts also anchor the pacts.
Not all diseases receive equal emphasis, however. Tuberculosis appears in fewer than half the announcements, while malaria is omitted from some, like Côte d’Ivoire’s.[2] Global health security gains focus, with goals to detect outbreaks within seven days and respond in 72 hours.
- HIV/AIDS: Support 95-95-95 testing and treatment targets.
- Tuberculosis: 80 percent incidence reduction by 2030.
- Malaria: 90 percent mortality drop; elimination in 35 countries.
- Polio: Eradicate wild type 1 by 2027.
- Health Security: Rapid surveillance and response systems.
Diverse Commitments: From Nigeria’s Billions to Modest Increases
Co-financing varies widely, reflecting partners’ capacities. Nigeria committed $3 billion, covering 59 percent of its $5.1 billion deal. Botswana pledged the highest share at 78 percent, leveraging its stronger economy.[2]
Others, including Burundi, Dominican Republic, Madagascar, Malawi, Mozambique, and Uganda, finance less than a quarter. Malawi’s $936 million pact includes gradual domestic increases from a low base of 3 percent of its budget.[4] Panama’s $33.5 million agreement marks Central America’s first, with $11 million from local funds.
| Country | US Commitment | Co-Investment Share |
|---|---|---|
| Nigeria | $5.1 billion (total) | 59% |
| Botswana | Not specified | 78% |
| Malawi | $936 million | <25% |
| Panama | $22.5 million | ~33% |
| DRC | Up to $900 million | Not specified |
Democratic Republic of Congo signed for up to $900 million U.S. funding plus $300 million local. Recent additions include Honduras, Senegal, Guatemala, Guinea, and El Salvador.[5][6]
Capacity Concerns Amid Economic Pressures
Analysts question whether all partners can meet pledges. African nations average 7 percent of budgets for health, far below the 15 percent Abuja target.[2] High debt burdens, like Mozambique’s 97 percent of GDP, complicate matters.
Some projections show total health spending declining despite co-investments, as in Liberia (6 percent drop by 2030) and Mozambique (17 percent). Negotiations stalled for Zambia and Zimbabwe over data-sharing.[2] Full MOU texts remain scarce, limiting transparency.
Key Takeaways
- 24 countries have signed MOUs totaling nearly $20 billion through 2030.[2]
- Partners commit 37 percent overall, with shares from under 25 percent to 78 percent.
- Focus on infectious diseases and security, but gaps in TB, malaria, and NCDs persist.
These agreements reshape U.S. global health leadership toward accountability and sustainability. For the latest details, consult the KFF Tracker.[1] As implementation unfolds this year, outcomes will test the strategy’s promise. What do you think of this partnership model? Share your views in the comments.
